Butastat may be available in the countries listed below.
Ingredient matches for Butastat
Scopolamine is reported as an ingredient of Butastat in the following countries:
- Bangladesh
International Drug Name Search
Butastat may be available in the countries listed below.
Scopolamine is reported as an ingredient of Butastat in the following countries:
International Drug Name Search
Laroxyl may be available in the countries listed below.
Amitriptyline is reported as an ingredient of Laroxyl in the following countries:
Amitriptyline hydrochloride (a derivative of Amitriptyline) is reported as an ingredient of Laroxyl in the following countries:
International Drug Name Search
Sophipren may be available in the countries listed below.
Prednisolone 21-acetate (a derivative of Prednisolone) is reported as an ingredient of Sophipren in the following countries:
International Drug Name Search
Cetaler may be available in the countries listed below.
Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cetaler in the following countries:
International Drug Name Search
Minrin may be available in the countries listed below.
Desmopressin acetate (a derivative of Desmopressin) is reported as an ingredient of Minrin in the following countries:
International Drug Name Search
In the US, Auro (carbamide peroxide otic) is a member of the drug class cerumenolytics and is used to treat Ear Wax Impaction.
US matches:
Urea peroxyde (a derivative of Urea) is reported as an ingredient of Auro in the following countries:
International Drug Name Search
Generic Name: buprenorphine (injection) (byoo pre NOR feen)
Brand Names: Buprenex
Buprenorphine is a narcotic pain medicine similar to morphine.
Buprenorphine is used to treat moderate to severe pain.
Buprenorphine may also be used for purposes not listed in this medication guide.
To make sure you can safely use buprenorphine, tell your doctor if you have any of these other conditions:
asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, or other breathing disorders;
liver or kidney disease;
a thyroid disorder;
enlarged prostate, urination problems;
gallbladder disease;
curvature of the spine;
Addison's disease (adrenal gland disorder);
a history of mental illness, personality disorder, or psychotic episode;
a history of drug or alcohol addiction; or
a history of seizures, head injury, or brain tumor.
Buprenorphine is injected into a muscle or into a vein through an IV. You may be shown how to use injections at home. Do not self-inject this medicine if you do not fully understand how to give the injection and properly dispose of used needles, syringes, IV tubing, and other items used to inject the medicine.
Buprenorphine is usually given at evenly spaced intervals, up to 6 hours apart. Tell your doctor if buprenorphine does not relieve your pain within 1 hour after an injection.
Prepare your dose in a syringe or IV only when you are ready to give yourself an injection. Do not use the medication if it has changed colors or has particles in it. Call your doctor for a new prescription. Use a disposable needle only once. Throw away used needles in a puncture-proof container (ask your pharmacist where you can get one and how to dispose of it). Keep this container out of the reach of children and pets.
Since buprenorphine is used on an as needed basis, you are not likely to miss a dose. Never use buprenorphine in larger amounts, or more often than recommended by your doctor.
Like other narcotic medicines, buprenorphine can slow your breathing. Death may occur if breathing becomes too weak.
weak or shallow breathing, feeling light-headed, fainting;
blue lips or fingernails;
confusion, feelings of extreme happiness;
fast or slow heart rate; or
urinating less than usual or not at all.
Less serious side effects may include:
dizziness, spinning sensation, weakness, tired feeling;
nausea, vomiting, constipation;
increased sweating, numbness or tingly feeling;
headache, depressed mood; or
blurred vision, double vision.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Usual Adult Dose for Opiate Dependence:
Initial dose: 8 mg sublingually on day 1.
Maintenance dose: Rapidly titrate to the recommended target dose of 16 mg/day. In clinical trials, patients received 8 mg on day 1 and 16 mg on day 2 and thereafter. Further dose adjustments may be made in 2 mg to 4 mg increments up to a level that suppresses opioid withdrawal symptoms and holds the patient in treatment. The usual daily range is 4 mg to 24 mg sublingually.
The tablets should be placed under the tongue at the same time and allowed to dissolve. If patients are taking more than 2 tablets per dose and cannot hold more than 2 under the tongue comfortably, they should use 2 tablets at a time, allowing them to dissolve completely before taking more tablets.
For patients taking heroin or short-acting opioids, the first dose should be administered at least 4 hours after the patient last used opioids or preferably when early withdrawal symptoms appear.
Withdrawal symptoms may occur during buprenorphine induction treatment of patients taking methadone or long-acting opioids, especially high opioid doses or when buprenorphine is administered shortly after the last opioid dose. The optimal time for the first dose has not been reported.
The optimal method of tapering to discontinuation has not been reported.
Usual Adult Dose for Pain:
IM or IV:
Initial: 0.3 mg slow IM or IV every 6 hours as needed. May repeat once 30 to 60 minutes after the initial dose. Maximum single dose: 0.6 mg (IM only)
Transdermal patches: Apply 1 patch to a hairless or nearly hairless intact skin site. There are 8 possible application sites: upper outer arm, upper chest, upper back, and side of the chest (on both sides of the body). The patch is worn for 7 days. Maximum dose: 20 mcg/hour
Usual Pediatric Dose for Pain:
Less than 2 years: Safety and effectiveness have not been established.
2 to 12 years: 2 to 6 mcg/kg IM or slow IV every 4 to 6 hours.
13 to 18 years: 0.3 mg IM or slow IV every 6 hours; may repeat dose in 30 to 60 minutes.
Tell your doctor about all other medicines you use, especially:
dexamethasone (Cortastat, Dexasone, Solurex, DexPak);
imatinib (Gleevec);
isoniazid (for treating tuberculosis);
nefazodone;
St. John's wort;
an antibiotic such as clarithromycin (Biaxin), erythromycin (E.E.S., EryPed, Ery-Tab, Erythrocin, Pediazole), rifabutin (Mycobutin), rifampin (Rifadin, Rifater, Rifamate), rifapentine (Priftin), or telithromycin (Ketex);
antifungal medication such as itraconazole (Sporanox), ketoconazole (Nizoral), or miconazole (Oravig);
a barbiturate such as butabarbital (Butisol), secobarbital (Seconal), pentobarbital (Nembutal), or phenobarbital (Solfoton);
a blood thinner such as warfarin (Coumadin, Jantoven);
heart or blood pressure medication such as nicardipine (Cardene) or quinidine (Quin-G);
HIV/AIDS medicine such as atazanavir (Reyataz), delavirdine (Rescriptor), efavirenz (Sustiva, Atripla), etravirine (Intelence), indinavir (Crixivan), nelfinavir (Viracept), nevirapine (Viramune), saquinavir (Invirase), or ritonavir (Norvir, Kaletra);
an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate);
medicines to treat narcolepsy, such as armodafinil (Nuvigil) or modafinil (Progivil);
a phenothiazine such as chlorpromazine (Thorazine), fluphenazine (Permitil, Prolixin), perphenazine (Trilafon), prochlorperazine (Compazine, Compro), promethazine (Pentazine, Phenergan, Anergan, Antinaus), thioridazine (Mellaril), or trifluoperazine (Stelazine);
a sedative such as diazepam (Valium), midazolam (Versed), alprazolam (Xanax) lorazepam (Ativan), clorazepate (Tranxene), triazolam (Halcion), flurazepam (Dalmane), or temazepam (Restoril); or
seizure medication such as carbamazepine (Carbatrol, Equetro, Tegretol), felbamate (Felbatol), oxcarbazepine (Trileptal), phenytoin (Dilantin), or primidone (Mysoline).
This list is not complete and other drugs may interact with buprenorphine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
See also: buprenorphine side effects (in more detail)
Aciclovir Topico Mabo may be available in the countries listed below.
Aciclovir is reported as an ingredient of Aciclovir Topico Mabo in the following countries:
International Drug Name Search
Nitroplast may be available in the countries listed below.
Nitroglycerin is reported as an ingredient of Nitroplast in the following countries:
International Drug Name Search
Ena-Puren comp may be available in the countries listed below.
Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Ena-Puren comp in the following countries:
Hydrochlorothiazide is reported as an ingredient of Ena-Puren comp in the following countries:
International Drug Name Search
Potassio Fosfato Monico may be available in the countries listed below.
Potassium Phosphate, Dibasic is reported as an ingredient of Potassio Fosfato Monico in the following countries:
Potassium Phosphate, Monobasic is reported as an ingredient of Potassio Fosfato Monico in the following countries:
International Drug Name Search